PATENTS - Criteria for patent protection - Non-obviousness
Wednesday, May 17, 2023 @ 5:57 AM
Appeal by Teva Canada Limited (Teva) and cross-appeal by Janssen Inc. and Janssen Pharmaceutica NV (Janssen) from Federal Court judgment for patent infringement. Teva argued that the Federal Court made reviewable...